Hemoglobinopathies Market Worth $15.7 Billion By 2028 | CAGR: 10.8%
Hemoglobinopathies Industry Overview The global hemoglobinopathies market size is expected to reach USD 15.7 billion by 2028, according to a new report by Grand View Research, Inc. It is expected to expand at a CAGR of 10.8% from 2021 to 2028. Increasing awareness regarding hemoglobinopathies and government initiatives to diagnose the diseases at an early stage are expected to propel the market growth over the forecast period. Moreover, increasing R&D investment, the presence of a promising drug pipeline, and technologically advanced diagnostics platforms are expected to boost the growth of the market. Hemoglobinopathies Market Segmentation Grand View Research has segmented the global hemoglobinopathies market on the basis of type, diagnosis, therapy, and region: Based on the Type Insights, the market is segmented into Thalassemia, Sickle Cell Disease, Other Hemoglobin (Hb) Variants. The sickle cell disease segment held the largest share of 56.6% in 2020 and i...